Notman Donald

Notman Donald is listed in filings as Chief Operating Officer at Ocular Therapeutix, Inc.. This profile follows SEC Form 4 activity through Feb 17, 2026, including sale activity. Recent filings connect the profile to Ocular Therapeutix, Inc. (OCUL). The current snapshot covers public activity from Sep 3, 2024 to Feb 17, 2026. Reported amounts are shown as $103.5K to $49.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.